Boundless Bio, Inc.(BOLD) - 2025 Q2 - Quarterly Report
Boundless Bio, Inc.(US:BOLD)2025-08-05 11:10UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______________ to ____________ Commission File Number: 001-41989 BOUNDLESS BIO, INC. (Exact Name of Registrant as Specified in its Charter) | Delaware | 83-0751 ...